This fact sheet describes the positive impact that adjuvants can have on vaccine efficacy and, potentially, immunization program costs. It also describes PATH’s work to expand global access to proprietary and non-proprietary adjuvants as well as relevant formulations technologies to facilitate their successful exploration and use by product development partnerships and developing-country vaccine manufacturers.

Author(s): PATH

Published: 2012

Resource types: PATH resource; Fact sheet

Diseases: Not disease/vaccine specific

Topics: Presentation and packaging

Regions: Global